entertainment -WSS

entertainment

author：explore 2025-10-02 11:09:08 - browse：6

Emma Walmsley on stage at the 2023 STAT Summit. — GSK CEO Emma Walmsley at the 2023 STAT Summit. STAT

The story of GSK is one of reinvention, CEO Emma Walmsley said at the STAT Summit in Boston on Thursday. Having shed its consumer division, the British drug giant is writing a new chapter as a pure-play biopharma company dedicated to the prevention, as well as treatment, of disease.

GSK’s recent launch of a new RSV vaccine for adults is emblematic of this move, adding to a portfolio that includes other vaccines, such as the very successful Shingrix for shingles, as well as drugs for HIV, other infectious diseases, and cancer, among others. But what does the growing sentiment against vaccination, not just in the United States but around the world, mean for such a bet on this market?

“It’s a very, very serious issue,” Walmsley said, noting that in 11 U.S. states, basic vaccination rates are now lower than they were before Covid. “The answer can’t be sort of flinging science over the airwaves and saying ‘trust us,’ because people don’t. There is a really serious challenge of misinformation and the ongoing issue of politicization, which I suspect is going to get more challenging in the next year for obvious reasons.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Health Care Service Corp to buy Cigna Medicare Advantage plans

WSS

Ancient Greek ideas underpin modern concepts of pregnancy

The Affordable Care Act has saved billions in health care costs

$1 billion proposal to grow Boston, Massachusetts biotech

Philips to halt sales of sleep apnea machines in U.S.

New clues to why women have higher risk of autoimmune disorders

Venture capital firm's plans to take over Akron hospital face hurdles

focus

entertainment

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

A new approach to psychiatric drug development

23andMe had bad news about my health. I wish a person had delivered it

Change Healthcare: What is it, why does its cyberattack matter?

At least 13 dead in Texas as scorching temps continue

Longer MASH drug regimen improved liver, Akero study finds

23andMe had bad news about my health. I wish a person had delivered it

Medicare Advantage insurers face 0.2% cut to 2025 payments

Wildfire smoke exposes gaps in outdoor worker protections

State of the Union pitch: Bigger Medicare drug price negotiations

explore

10 reasons why health care startups fail

Why you shouldn’t ask, “What country has the best health care?”

The untold story of TV’s first prescription drug ad

FTC sues over Novant Health acquisition of two N.C. hospitals

Zyn nicotine pouches become unlikely player in latest culture war

Biden's 'march

focus

hotspot

focus

focus